High Net Worth Advisory Group LLC

Position in ACLX — Arcellx, Inc.

CIK 1919142 NAPLES, FL

Position in ACLX

as of Mar 31, 2026 · filed Apr 17, 2026 Compact

Position Value

$918,560

+$396,960 QoQ

Shares Held

8,000

0.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

#127

of 238 holders

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

High Net Worth Advisory Group LLC holds $3,315,565 across 8 Biotechnology names. ACLX ranks #1 (27.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc. This page	8,000	$918,560
2	BLTE	Belite Bio, Inc	3,500	$558,040
3	ALNY	Alnylam Pharmaceuticals, Inc.	1,500	$496,305
4	ARGX	Argenx SE	500	$365,125
5	CYTK	Cytokinetics Inc	5,000	$329,550
6	NUVL	Nuvalent, Inc.	3,000	$307,350
7	SYRE	Spyre Therapeutics, Inc.	6,000	$302,640
8	GERN	Geron Corp	25,500	$37,995

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$918,560	8,000	0.0%	Shares	Sole	2026-04-17
2025-12-31	$521,600	8,000	0.0%	Shares	Sole	2026-01-23
2025-09-30	$656,800	8,000	0.0%	Shares	Sole	2025-10-29
2025-06-30	$526,800	8,000	-5.9%	Shares	Sole	2025-07-10
2025-03-31	$557,600	8,500	0.0%	Shares	Sole	2025-04-09
2024-12-31	$651,865	8,500	0.0%	Shares	Sole	2025-01-21
2024-09-30	$709,835	8,500	+6.2%	Shares	Sole	2024-10-11
2024-06-30	$441,520	8,000	0.0%	Shares	Sole	2024-07-17
2024-03-31	$556,400	8,000	+14.3%	Shares	Sole	2024-04-12
2023-12-31	$388,500	7,000	+7.7%	Shares	Sole	2024-01-08
2023-09-30	$233,220	6,500	+62.5%	Shares	Sole	2023-10-05
2022-12-31	$123,920	4,000	+60.0%	Shares	Sole	2023-02-14
2022-09-30	$46,925	2,500	+66.7%	Shares	Sole	2022-10-24
2022-06-30	$27,120	1,500	0.0%	Shares	Sole	2022-08-10
2022-03-31	$21,030	1,500	—	Shares	Sole	2022-08-10
No filing history on record for this holder in this stock.